GXCClass III
Device, Electroconvulsive Therapy
21 CFR 882.5940 / Neurology
GXC is the FDA product code for Device, Electroconvulsive Therapy, a class III device type, regulated under 21 CFR 882.5940. As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- GXC
- Device name
- Device, Electroconvulsive Therapy
- Regulation
- 21 CFR 882.5940
- Device class
- Class III
- Review panel
- Neurology
- Submission type
- PMA
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
